Abstract
Purpose
Children with chronic conditions experience medical issues over long-term periods of time which can have lasting emotional and social consequences impacting daily life and functioning. Activities and participation outcomes are needed in order to comprehensively assess child-important health in clinical trials. Our objective was to review the extent to which activity and participation outcomes are included in clinical trials of childhood chronic disease and to determine what trial characteristics are associated with their use.
Methods
A review of a large clinical trial registration database (clinicaltrials.gov) was conducted over the 2010 calendar year. The measures used to assess primary and secondary endpoints were coded according to the ICF classification system. Trial characteristics that might be associated with activity and participation outcome use such as sponsorship type, intervention type, health condition, whether the trial was focused on pediatric patients, phase of trial and sample size were also extracted and explored with univariable and multivariable regressions.
Results
Four hundred and ninety-nine trials met inclusion criteria, 495 of which had complete information about hypothesized predictors. Only 36 out of 495 trials included an activity and participation outcome as part of the trial evaluation process. Both univariable and multivariable regression models showed that non-drug trials and late phase of trial (phase IV) showed the strongest likelihood with whether a trial would include an activity and participation outcome.
Discussion
Most registered clinical trials for children with chronic or ongoing medical conditions do not include a comprehensive approach to health outcomes assessment, especially drug trials and early phase trials. Outcome measures in pediatric clinical trials are lagging relative to World Health Organization standards for comprehensive health evaluation.
Similar content being viewed by others
References
Zhang, B., & Schmidt, B. (2001). Do we measure the right end points? A systematic review of primary outcomes in recent neonatal randomized clinical trials. Journal of Pediatrics, 138(1), 76–80.
Sinha, I. P., Williamson, P. R., & Smyth, R. L. (2009). Outcomes in clinical trials of inhaled corticosteroids for children with asthma are narrowly focussed on short term disease activity. PLoS One, 4(7), e6276.
Sinha, I. P., Altman, D. G., Beresford, M. W., Boers, M., Clarke, M., Craig, J., et al. (2012). Standard 5: Selection, measurement, and reporting of outcomes in clinical trials in children. Pediatrics, 129(Supplement 3), S146–S152.
Schulz, Kenneth F., Altman, Douglas G., & Moher, David. (2010). CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials. BMC Medicine, 8(1), 18.
Jüni, P., Altman, D. G., & Egger, M. (2001). Assessing the quality of controlled clinical trials. BMJ, 323(7303), 42–46.
Clarke, S. A., & Eiser, C. (2004). The measurement of health-related quality of life (QOL) in paediatric clinical trials: A systematic review. Health Qual Life Outcomes, 2(1), 66.
Cohen, E., Goldman, R. D., Ragone, A., Uleryk, E., Atenafu, E. G., Siddiqui, U., et al. (2010). Child vs adult randomized controlled trials in specialist journals: A citation analysis of trends, 1985–2005. Archives of Pediatrics and Adolescent Medicine, 164(3), 283.
Selby, J. V., Beal, A. C., & Frank, L. (2012). The Patient-Centered Outcomes Research Institute (PCORI) national priorities for research and initial research agenda. JAMA: The Journal of the American Medical Association, 307(15), 1583–1584.
U.S. Food and Drug Administration. (2009). Patient reported outcome measures: Use in medical product development to support labeling claims. Available at: www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm071975.pdf.
Speight, J., & Barendse, S. M. (2010). FDA guidance on patient reported outcomes. British Medical Journal, 340, c2921.
World Health Organization. (2007). International classification of functioning, disability, and health : Children & youth version : ICF-CY. Geneva: World Health Organization.
World Health Organization. (2001). International classification of functioning, disability and health : ICF. Geneva: World Health Organization.
Schiariti, V., Fayed, N., Cieza, A., Klassen, A., & O’donnell, M. (2010). Content comparison of health-related quality of life measures for cerebral palsy based on the International Classification of Functioning. Disability & Rehabilitation (0), 1–10.
Fayed, N., & Kerr, E. N. (2011). International Journal of Disability, Community & Rehabilitation Available at: http://www.ijdcr.ca/VOL08_03/articles/fayed.shtml. Accessed 24 February 2011.
Fayed, N., Schiariti, V., Bostan, C., Cieza, A., & Klassen, A. (2011). Health status and QOL instruments used in childhood cancer research: Deciphering conceptual content using World Health Organization definitions. Quality of Life Research, 20(8), 1247–1258.
Fayed, N., Kraus de Camargo, O., Kerr, E., Rosenbaum, P., Dubey, A., Bostan, C., Faulhaber, M., Raina, P., & Cieza, A. (2012). Generic child health status and quality of life instruments: A review of conceptual content using WHO definitions. Developmental Medicine Child Neurology, 54(12), 1085–1095.
Fayed, N. (2011). Linking health and health-related information to the ICF: A systematic review of the literature from 2001 to 2008. Disability Rehability, 1.
Institute of Medicine. (2004) Children’s health, the nation’s wealth: Assessing and improving child health, Washington: National Academies Press.
Fayed, N., Cieza, A., & Bickenbach, J. (2012). Illustrating child-specific linking issues using the child health questionnaire. American Journal of Physical Medicine and Rehabilitation, 91(13), S189.
Cieza, A. (2002). Linking health-status measurements to the international classification of functioning, disability and health. Journal of Rehabilitation Medicine, 34(5), 205.
Chafe, R., Born, K. B., Slutsky, A. S., & Laupacis, A. (2011). The rise of people power. Nature, 472(7344), 410–411.
Adolfsson, M. (2011). Applying the ICF-CY to identify everyday life situations of children and youth with disabilities. Thesis, School of Education and Communication, Jönköping University.
Partridge, N., & Scadding, J. (2004). The James Lind Alliance: Patients and clinicians should jointly identify their priorities for clinical trials. The Lancet, 364(9449), 1923–1924.
Acknowledgments
Nora Fayed is a recipient of the Canadian Institute of Health Research postdoctoral fellowship and thanks postdoctoral mentor Aileen Davis for comments and editing support.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fayed, N., de Camargo, O.K., Elahi, I. et al. Patient-important activity and participation outcomes in clinical trials involving children with chronic conditions. Qual Life Res 23, 751–757 (2014). https://doi.org/10.1007/s11136-013-0483-9
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11136-013-0483-9